177 related articles for article (PubMed ID: 33107985)
1. Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian Rare Cancer Network.
Stacchiotti S; Simeone N; Lo Vullo S; Baldi GG; Brunello A; Vincenzi B; Palassini E; Dagrada G; Collini P; Morosi C; Greco FG; Sbaraglia M; Dei Tos AP; Mariani L; Frezza AM; Casali PG
Cancer; 2021 Feb; 127(4):569-576. PubMed ID: 33107985
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database.
Stacchiotti S; Provenzano S; Dagrada G; Negri T; Brich S; Basso U; Brunello A; Grosso F; Galli L; Palassini E; Libertini M; Colia V; Gronchi A; Dei Tos AP; Crippa F; Morosi C; Pilotti S; Casali PG
Ann Surg Oncol; 2016 Sep; 23(9):2735-44. PubMed ID: 27334221
[TBL] [Abstract][Full Text] [Related]
3. Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature.
Frezza AM; Ravi V; Lo Vullo S; Vincenzi B; Tolomeo F; Chen TW; Teterycz P; Baldi GG; Italiano A; Penel N; Brunello A; Duffaud F; Hindi N; Iwata S; Smrke A; Fedenko A; Gelderblom H; Van Der Graaf W; Vozy A; Connolly E; Grassi M; Benjamin RS; Broto JM; Grignani G; Jones RL; Kawai A; Tysarowski A; Mariani L; Casali PG; Stacchiotti S
Cancer Med; 2021 Apr; 10(8):2645-2659. PubMed ID: 33713582
[TBL] [Abstract][Full Text] [Related]
4. Clinical prognostic factors in advanced epithelioid haemangioendothelioma: a retrospective case series analysis within the Italian Rare Cancers Network.
Frezza AM; Napolitano A; Miceli R; Badalamenti G; Brunello A; Buonomenna C; Casali PG; Caraceni A; Grignani G; Gronchi A; Infante G; Morosi C; Saita L; Simeone N; Zaffaroni N; Vincenzi B; Stacchiotti S
ESMO Open; 2021 Apr; 6(2):100083. PubMed ID: 33714008
[TBL] [Abstract][Full Text] [Related]
5. A Retrospective Review of the Use of Sirolimus for Pediatric Patients With Epithelioid Hemangioendothelioma.
Engel ER; Cournoyer E; Adams DM; Stapleton S
J Pediatr Hematol Oncol; 2020 Nov; 42(8):e826-e829. PubMed ID: 31714437
[TBL] [Abstract][Full Text] [Related]
6. Cytologic features and immunohistochemical findings of epithelioid hemangioendothelioma (EHE) in effusion: A case series.
Jebastin Thangaiah J; Hanley K; Nomani L; Policarpio-Nicolas ML
Diagn Cytopathol; 2021 Jan; 49(1):E24-E30. PubMed ID: 32797671
[TBL] [Abstract][Full Text] [Related]
7. Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant.
Li S; Dermawan JK; Seavey CN; Ma S; Antonescu CR; Rubin BP
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23226. PubMed ID: 38380774
[TBL] [Abstract][Full Text] [Related]
8. New Molecular Insights, and the Role of Systemic Therapies and Collaboration for Treatment of Epithelioid Hemangioendothelioma (EHE).
Stacchiotti S; Tap W; Leonard H; Zaffaroni N; Baldi GG
Curr Treat Options Oncol; 2023 Jun; 24(6):667-679. PubMed ID: 37058275
[TBL] [Abstract][Full Text] [Related]
9. Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.
Gounder M; Schöffski P; Jones RL; Agulnik M; Cote GM; Villalobos VM; Attia S; Chugh R; Chen TW; Jahan T; Loggers ET; Gupta A; Italiano A; Demetri GD; Ratan R; Davis LE; Mir O; Dileo P; Van Tine BA; Pressey JG; Lingaraj T; Rajarethinam A; Sierra L; Agarwal S; Stacchiotti S
Lancet Oncol; 2020 Nov; 21(11):1423-1432. PubMed ID: 33035459
[TBL] [Abstract][Full Text] [Related]
10. Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions.
Anderson T; Zhang L; Hameed M; Rusch V; Travis WD; Antonescu CR
Am J Surg Pathol; 2015 Jan; 39(1):132-9. PubMed ID: 25353289
[TBL] [Abstract][Full Text] [Related]
11. The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis.
Baldi GG; Brahmi M; Lo Vullo S; Cojocaru E; Mir O; Casanova M; Vincenzi B; De Pas TM; Grignani G; Pantaleo MA; Blay JY; Jones RL; Le Cesne A; Frezza AM; Gronchi A; Collini P; Dei Tos AP; Morosi C; Mariani L; Casali PG; Stacchiotti S
Oncologist; 2020 Nov; 25(11):e1777-e1784. PubMed ID: 32584482
[TBL] [Abstract][Full Text] [Related]
12. Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years.
Blay JY; Piperno-Neumann S; Watson S; Dufresne A; Valentin T; Duffaud F; Toulmonde M; Italiano A; Bertucci F; Tlemsani C; Firmin N; Bompas E; Perrin C; Ropars M; Saada-Bouzid E; Dubray-Longeras P; Hervieu A; Lebbe C; Gantzer J; Chaigneau L; Fiorenza F; Rios M; Isambert N; Soibinet P; Boudou-Roquette P; Verret B; Ferron G; Ryckewaert T; Lebellec L; Brahmi M; Gouin F; Meeus P; Vaz G; Le Loarer F; Karanian M; De Pinieux G; Ducimetiere F; Chemin C; Morelle M; Le Cesne A; Penel N;
Eur J Cancer; 2023 Oct; 192():113262. PubMed ID: 37625241
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO).
Chevreau C; Le Cesne A; Ray-Coquard I; Italiano A; Cioffi A; Isambert N; Robin YM; Fournier C; Clisant S; Chaigneau L; Bay JO; Bompas E; Gauthier E; Blay JY; Penel N
Cancer; 2013 Jul; 119(14):2639-44. PubMed ID: 23589078
[TBL] [Abstract][Full Text] [Related]
14. Clinical characterization and long-term outcomes in pediatric epithelioid hemangioendothelioma.
Cournoyer E; Al-Ibraheemi A; Engel E; Chaudry G; Stapleton S; Adams DM
Pediatr Blood Cancer; 2020 Feb; 67(2):e28045. PubMed ID: 31724797
[TBL] [Abstract][Full Text] [Related]
15. Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial.
Hurvitz SA; Andre F; Jiang Z; Shao Z; Mano MS; Neciosup SP; Tseng LM; Zhang Q; Shen K; Liu D; Dreosti LM; Burris HA; Toi M; Buyse ME; Cabaribere D; Lindsay MA; Rao S; Pacaud LB; Taran T; Slamon D
Lancet Oncol; 2015 Jul; 16(7):816-29. PubMed ID: 26092818
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell malignancies in infants, children and adolescents: Treatment results of three Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Sparber-Sauer M; Koscielniak E; Vokuhl C; Schmid I; Bien E; Seitz G; Hallmen E; von Kalle T; Scheer M; Münter M; Bielack SS; Niggli F; Ljungman G; Fuchs J; Hettmer S; Rössler J; Klingebiel T;
Pediatr Blood Cancer; 2020 Mar; 67(3):e28095. PubMed ID: 31814291
[TBL] [Abstract][Full Text] [Related]
17. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites.
Errani C; Zhang L; Sung YS; Hajdu M; Singer S; Maki RG; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2011 Aug; 50(8):644-53. PubMed ID: 21584898
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus for patients with progressive epithelioid hemangioendothelioma.
Smrke AM; Huang PH; Jones RL
Cancer; 2021 Feb; 127(4):504-506. PubMed ID: 33107994
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants.
Patel NR; Salim AA; Sayeed H; Sarabia SF; Hollingsworth F; Warren M; Jakacky J; Tanas M; Oliveira AM; Rubin BP; Lazar AJ; López-Terrada D; Wang WL
Histopathology; 2015 Nov; 67(5):699-708. PubMed ID: 25817592
[TBL] [Abstract][Full Text] [Related]
20. Systemic treatment options for epithelioid haemangioendothelioma: the Royal Marsden Hospital experience.
Yousaf N; Maruzzo M; Judson I; Al-Muderis O; Fisher C; Benson C
Anticancer Res; 2015 Jan; 35(1):473-80. PubMed ID: 25550590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
